FDA shuffles top drug, biologics leaders in latest shakeup

The U.S. Food and Drug Administration is reorganizing its top drug and biologics regulators after the departure of former commissioner Marty Makary. This change occurs days after Makary's exit. The shuffle affects key leadership positions.